Company Filing History:
3 out of 23 
2 out of 5 
1 out of 7 Years Active: 2024-2025
Title: Innovations by Jung Won Woo in Growth Hormone Treatment
Introduction
Jung Won Woo is a notable inventor based in Seoul, South Korea. He has made significant contributions to the field of medicine, particularly in the treatment of growth hormone deficiencies. With a total of three patents to his name, his work has the potential to impact pediatric healthcare positively.
Latest Patents
Jung Won Woo's latest patents include a method for treating growth hormone deficiency employing a human growth hormone fusion protein. This method involves administering a pharmaceutical composition containing the hGH fusion protein (GX-H9). The administration can occur once a week at a dose of 0.4 to 1.6 mg per body weight kg of a pediatric patient or once every two weeks at a dose of 0.8 to 3.2 mg per body weight kg. Another significant patent is a pharmaceutical composition comprising recombinant hGH for the treatment of growth hormone deficiency. This method includes administering recombinant human growth hormone GX-H9 once a week with a dosage of 0.1 to 0.3 mg per weight kg of a patient or twice-monthly with a dosage of 0.1 to 0.4 mg per weight kg.
Career Highlights
Throughout his career, Jung Won Woo has worked with prominent companies in the pharmaceutical industry, including Genexine, Inc. and Handok Inc. His experience in these organizations has allowed him to develop innovative solutions for treating growth hormone deficiencies.
Collaborations
Jung Won Woo has collaborated with notable colleagues such as Tae Kyung Kim and Woo Ick Jang. These partnerships have contributed to the advancement of his research and the development of his patents.
Conclusion
Jung Won Woo's contributions to the field of growth hormone treatment demonstrate his commitment to improving pediatric healthcare. His innovative patents and collaborations highlight the importance of research in developing effective medical solutions.